Roche honored with a MarketingSherpa award
Roche's Imaginality 2008 website created an intelligent link between science and literature. Every month, the site introduced its visitors to another exciting science thriller and points out Roche products that could have played a role in the context of the novel. Each visitor was automatically entered into a drawing for a book or CD. The recently honored e-mail campaign was launched to advertise the Imaginality 2008 site.
MarketingSherpa (www.marketingsherpa.com) is a marketing research institute located in Warren, Rhode Island. As part of its research activities, the institute performs lab tests, conducts surveys of marketing experts and marketing prospects and customers and holds in-depth interviews with marketing officials from notable companies in business-to-business and consumer marketing. MarketingSherpa also analyzes the publications of other marketing research institutes.
About Roche Diagnostics Deutschland GmbH
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.
In 2008, Roche had over 80,000 employees worldwide and invested almost 9 billion Swiss francs in R&D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.
Weitere Pressemitteilungen dieses Herausgebers
- 16.03.2015 - Nachweis des Krankenhauskeimes MRSA
- 11.03.2015 - German Life Science Award 2015
- 10.03.2015 - Roche führt molekulardiagnostischen Test zur Überwachung der HBV-Viruslast ein